The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Human Albumin-Global Market Insights and Sales Trends 2024
Synopsis
Albumin-based therapies such as Idelvion (CSL654 rIX-FP) by CSL Behring received marketing approval from the US FDA in March 2016 and from the EMA in May 2016. Apart from these, Albutropin (TV-1106) by Teva Pharmaceuticals, Ampion by Ampio Pharmaceuticals, and Albutein by Grifols (for Alzheimer's disease) are expected to enter the market during the forecast period.
The global Human Albumin market size is expected to reach US$ 6954 million by 2029, growing at a CAGR of 4.5% from 2023 to 2029. The market is mainly driven by the significant applications of Human Albumin in various end use industries. The expanding demands from the Therapeutics, Drug Formulation & Vaccine, Component of Media and Others, are propelling Human Albumin market. 5% Concentrations, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 25% Concentrations segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Human Albumin, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Human Albumin market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Human Albumin market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Human Albumin sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Human Albumin covered in this report include CSL Behring, Grifols, Baxalta, Octapharma and Kedrion, etc.
The global Human Albumin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
CSL Behring
Grifols
Baxalta
Octapharma
Kedrion
Global Human Albumin market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Human Albumin market, Segment by Type:
5% Concentrations
25% Concentrations
Others
Global Human Albumin market, by Application
Therapeutics
Drug Formulation & Vaccine
Component of Media
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Human Albumin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Human Albumin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Albumin-based therapies such as Idelvion (CSL654 rIX-FP) by CSL Behring received marketing approval from the US FDA in March 2016 and from the EMA in May 2016. Apart from these, Albutropin (TV-1106) by Teva Pharmaceuticals, Ampion by Ampio Pharmaceuticals, and Albutein by Grifols (for Alzheimer's disease) are expected to enter the market during the forecast period.
The global Human Albumin market size is expected to reach US$ 6954 million by 2029, growing at a CAGR of 4.5% from 2023 to 2029. The market is mainly driven by the significant applications of Human Albumin in various end use industries. The expanding demands from the Therapeutics, Drug Formulation & Vaccine, Component of Media and Others, are propelling Human Albumin market. 5% Concentrations, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 25% Concentrations segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Human Albumin, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Human Albumin market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Human Albumin market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Human Albumin sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Human Albumin covered in this report include CSL Behring, Grifols, Baxalta, Octapharma and Kedrion, etc.
The global Human Albumin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
CSL Behring
Grifols
Baxalta
Octapharma
Kedrion
Global Human Albumin market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Human Albumin market, Segment by Type:
5% Concentrations
25% Concentrations
Others
Global Human Albumin market, by Application
Therapeutics
Drug Formulation & Vaccine
Component of Media
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Human Albumin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Human Albumin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Human Albumin Market Overview
1.1 Human Albumin Product Overview
1.2 Human Albumin Market Segment by Type
1.2.1 5% Concentrations
1.2.2 25% Concentrations
1.2.3 Others
1.3 Global Human Albumin Market Size by Type
1.3.1 Global Human Albumin Market Size Overview by Type (2018-2029)
1.3.2 Global Human Albumin Historic Market Size Review by Type (2018-2023)
1.3.3 Global Human Albumin Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Human Albumin Sales Breakdown by Type (2018-2023)
1.4.2 Europe Human Albumin Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Human Albumin Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Human Albumin Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Human Albumin Sales Breakdown by Type (2018-2023)
2 Global Human Albumin Market Competition by Company
2.1 Global Top Players by Human Albumin Sales (2018-2023)
2.2 Global Top Players by Human Albumin Revenue (2018-2023)
2.3 Global Top Players by Human Albumin Price (2018-2023)
2.4 Global Top Manufacturers Human Albumin Manufacturing Base Distribution, Sales Area, Product Type
2.5 Human Albumin Market Competitive Situation and Trends
2.5.1 Human Albumin Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Human Albumin Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Albumin as of 2022)
2.7 Date of Key Manufacturers Enter into Human Albumin Market
2.8 Key Manufacturers Human Albumin Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Human Albumin Status and Outlook by Region
3.1 Global Human Albumin Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Human Albumin Historic Market Size by Region
3.2.1 Global Human Albumin Sales in Volume by Region (2018-2023)
3.2.2 Global Human Albumin Sales in Value by Region (2018-2023)
3.2.3 Global Human Albumin Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Human Albumin Forecasted Market Size by Region
3.3.1 Global Human Albumin Sales in Volume by Region (2024-2029)
3.3.2 Global Human Albumin Sales in Value by Region (2024-2029)
3.3.3 Global Human Albumin Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Human Albumin by Application
4.1 Human Albumin Market Segment by Application
4.1.1 Therapeutics
4.1.2 Drug Formulation & Vaccine
4.1.3 Component of Media
4.1.4 Others
4.2 Global Human Albumin Market Size by Application
4.2.1 Global Human Albumin Market Size Overview by Application (2018-2029)
4.2.2 Global Human Albumin Historic Market Size Review by Application (2018-2023)
4.2.3 Global Human Albumin Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Human Albumin Sales Breakdown by Application (2018-2023)
4.3.2 Europe Human Albumin Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Human Albumin Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Human Albumin Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Human Albumin Sales Breakdown by Application (2018-2023)
5 North America Human Albumin by Country
5.1 North America Human Albumin Historic Market Size by Country
5.1.1 North America Human Albumin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Human Albumin Sales in Volume by Country (2018-2023)
5.1.3 North America Human Albumin Sales in Value by Country (2018-2023)
5.2 North America Human Albumin Forecasted Market Size by Country
5.2.1 North America Human Albumin Sales in Volume by Country (2024-2029)
5.2.2 North America Human Albumin Sales in Value by Country (2024-2029)
6 Europe Human Albumin by Country
6.1 Europe Human Albumin Historic Market Size by Country
6.1.1 Europe Human Albumin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Human Albumin Sales in Volume by Country (2018-2023)
6.1.3 Europe Human Albumin Sales in Value by Country (2018-2023)
6.2 Europe Human Albumin Forecasted Market Size by Country
6.2.1 Europe Human Albumin Sales in Volume by Country (2024-2029)
6.2.2 Europe Human Albumin Sales in Value by Country (2024-2029)
7 Asia-Pacific Human Albumin by Region
7.1 Asia-Pacific Human Albumin Historic Market Size by Region
7.1.1 Asia-Pacific Human Albumin Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Human Albumin Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Human Albumin Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Human Albumin Forecasted Market Size by Region
7.2.1 Asia-Pacific Human Albumin Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Human Albumin Sales in Value by Region (2024-2029)
8 Latin America Human Albumin by Country
8.1 Latin America Human Albumin Historic Market Size by Country
8.1.1 Latin America Human Albumin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Human Albumin Sales in Volume by Country (2018-2023)
8.1.3 Latin America Human Albumin Sales in Value by Country (2018-2023)
8.2 Latin America Human Albumin Forecasted Market Size by Country
8.2.1 Latin America Human Albumin Sales in Volume by Country (2024-2029)
8.2.2 Latin America Human Albumin Sales in Value by Country (2024-2029)
9 Middle East and Africa Human Albumin by Country
9.1 Middle East and Africa Human Albumin Historic Market Size by Country
9.1.1 Middle East and Africa Human Albumin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Human Albumin Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Human Albumin Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Human Albumin Forecasted Market Size by Country
9.2.1 Middle East and Africa Human Albumin Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Human Albumin Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 CSL Behring
10.1.1 CSL Behring Company Information
10.1.2 CSL Behring Introduction and Business Overview
10.1.3 CSL Behring Human Albumin Sales, Revenue and Gross Margin (2018-2023)
10.1.4 CSL Behring Human Albumin Products Offered
10.1.5 CSL Behring Recent Development
10.2 Grifols
10.2.1 Grifols Company Information
10.2.2 Grifols Introduction and Business Overview
10.2.3 Grifols Human Albumin Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Grifols Human Albumin Products Offered
10.2.5 Grifols Recent Development
10.3 Baxalta
10.3.1 Baxalta Company Information
10.3.2 Baxalta Introduction and Business Overview
10.3.3 Baxalta Human Albumin Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Baxalta Human Albumin Products Offered
10.3.5 Baxalta Recent Development
10.4 Octapharma
10.4.1 Octapharma Company Information
10.4.2 Octapharma Introduction and Business Overview
10.4.3 Octapharma Human Albumin Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Octapharma Human Albumin Products Offered
10.4.5 Octapharma Recent Development
10.5 Kedrion
10.5.1 Kedrion Company Information
10.5.2 Kedrion Introduction and Business Overview
10.5.3 Kedrion Human Albumin Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Kedrion Human Albumin Products Offered
10.5.5 Kedrion Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Human Albumin Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Human Albumin Industrial Chain Analysis
11.4 Human Albumin Market Dynamics
11.4.1 Human Albumin Industry Trends
11.4.2 Human Albumin Market Drivers
11.4.3 Human Albumin Market Challenges
11.4.4 Human Albumin Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Human Albumin Distributors
12.3 Human Albumin Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
